Abiopharma

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

(99% Neutral) CVRx Inc. (CVRX) Announces Business Combination

(90% Positive) Elutia Inc (ELUT) Announces Regulatory Update

(70% Positive) Soleno Therapeutics Inc. (SLNO) Reports Q1 2026 Financial Results

(90% Positive) Foghorn Therapeutics Inc (FHTX) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Summit Plc - Current report filing

HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

New Form 424B5 - CVRx, Inc. Filed: 2026-01-12 AccNo: 0001104659-26-002741 Size: 451 KB

Director Smith Stan 🟢 acquired 22.7K shares of MAIA Biotechnology, Inc. (MAIA) at $3.69 Transaction Date: Sep 19, 2022 | Filing ID: 000021

(70% Positive) CRISPR Therapeutics (CRSP) Announces Clinical Development Update

(99% Positive) Inogen Inc (INGN) Reports Q1 2026 Financial Results

(85% Positive) Tarsus Pharmaceuticals Inc (TARS) Provides Update on XDEMVY for Demodex blepharitis

(90% Positive) Mirum Pharmaceuticals Inc (MIRM) Announces Enrollment Update for year Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment